Blue Cross Blue Shield of Michigan – Genetic Testing – May 1 2022 Update

Genetic Testing

The safety and effectiveness of genetic testing and counseling services have been established. They may be considered useful diagnostic options only if the testing results are expected to establish or verify a diagnosis, initiate a treatment plan or alter the patient’s health care management.

Exclusionary criteria have been updated, effective May 1, 2022.

Exclusions:

• Next-generation sequencing panels for conditions other than those listed under the Genetic Testing-NGS Testing of Multiple Genes (Panel) to Identify Targeted Cancer Therapy policy
• Whole genome or whole exome sequencing for conditions other than those listed under the Genetic Testing-Whole Exome and Whole Genome Sequencing for Diagnosis of Genetic Disorders policy
• Forensic testing for legal purposes

Source: https://www.bcbsm.com/content/dam/microsites/corpcomm/provider/the_record/2022/jun/Record_0622g.shtml